Delivery Order SPE2DB20D3505-SPE2DB21FU4E6
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,833.70 firm-fixed-price delivery order is for the supply of HAVRIX 1,440 UNIT/ML SYRINGE/ML, a vaccine product. The award has an ultimate completion date of June 26, 2023 and was made without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award, valued at $19,624.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of HAVRIX 1,440 UNIT/ML SYRINGE medical supplies. The contract has a firm fixed price and is a delivery order with an ultimate completion date of August 10, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of HAVRIX 1,440 units/mL syringes. The contract, valued at $62,346.24, is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $3,761.11, is for the delivery of the vaccine product HAVRIX 1,440 UNIT/ML SYRINGEML. The contract is a firm-fixed price delivery order with a period of performance through November 5, 2024. The contract does not have a set-aside designation, indicating open competition....
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Havrix 1,440 unit/mL syringes. The award, worth $3,667.40, has a firm-fixed price and an ultimate completion date of March 2, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, including the Department of Defense and Department of...
- This federal contract award, valued at $1,697.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract covers the delivery of 1,440 unit/mL syringes of the HAVRIX vaccine. This is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,854.50 firm fixed-price delivery order is for the supply of HAVRIX 1,440 UNIT/ML SYRINGE medical products, with a period of performance through October 2024. The contract was competitively awarded and does not have a set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,899.75 firm fixed-price delivery order is for the supply of HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML, a vaccine product. The contract has an ultimate completion date of August 26, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $5,009.28 Firm Fixed Price delivery order is for the supply of HAVRIX 1,440 Unit/mL syringes. This award is not associated with a set-aside program. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical, valued up to $999,999,999, and the Department of Justice Federal Bureau of Investigation,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Havrix 720 Unit/0.5 ML Syringes. The $9,211.50 firm fixed-price delivery order contract has an ultimate completion date of August 24, 2022. The contract is not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB21FU4E6Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (Contract ID: SPE2DB20D3505|SPE2DB21FU4E6) issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $7,143.84 firm-fixed-price award is for the delivery of HAVRIX 1,440 units/mL syringes. This contract does not have a set-aside designation, indicating full and open competition. Amerisourcebergen is a major pharmaceutical distributor that holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.1k | 9/10/21 |